{
    "paper_id": "f67ff2485f874c96ef058b1e545a9e8c21c8d35c",
    "metadata": {
        "title": "Pandemic-Potential, Risk Factors, and Patients' Perspective 5 Katharina Boehm The main goals for urologists during the coronavirus disease",
        "authors": [
            {
                "first": "",
                "middle": [],
                "last": "Q5",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Johannes Gutenberg University",
                    "location": {
                        "settlement": "Mainz",
                        "country": "Germany"
                    }
                },
                "email": ""
            },
            {
                "first": "Stefani",
                "middle": [],
                "last": "Ziewers",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Johannes Gutenberg University",
                    "location": {
                        "settlement": "Mainz",
                        "country": "Germany"
                    }
                },
                "email": ""
            },
            {
                "first": "Maximilian",
                "middle": [
                    "P"
                ],
                "last": "Brandt",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Johannes Gutenberg University",
                    "location": {
                        "settlement": "Mainz",
                        "country": "Germany"
                    }
                },
                "email": ""
            },
            {
                "first": "Peter",
                "middle": [],
                "last": "Sparwasser",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Johannes Gutenberg University",
                    "location": {
                        "settlement": "Mainz",
                        "country": "Germany"
                    }
                },
                "email": ""
            },
            {
                "first": "Maximilian",
                "middle": [
                    "Q3"
                ],
                "last": "Haack",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Johannes Gutenberg University",
                    "location": {
                        "settlement": "Mainz",
                        "country": "Germany"
                    }
                },
                "email": ""
            },
            {
                "first": "Franziska",
                "middle": [],
                "last": "Willems",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Johannes Gutenberg University",
                    "location": {
                        "settlement": "Mainz",
                        "country": "Germany"
                    }
                },
                "email": ""
            },
            {
                "first": "Anita",
                "middle": [],
                "last": "Thomas",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Johannes Gutenberg University",
                    "location": {
                        "settlement": "Mainz",
                        "country": "Germany"
                    }
                },
                "email": ""
            },
            {
                "first": "Robert",
                "middle": [],
                "last": "Dotzauer",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Johannes Gutenberg University",
                    "location": {
                        "settlement": "Mainz",
                        "country": "Germany"
                    }
                },
                "email": ""
            },
            {
                "first": "Thomas",
                "middle": [],
                "last": "H\u00f6fner",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Johannes Gutenberg University",
                    "location": {
                        "settlement": "Mainz",
                        "country": "Germany"
                    }
                },
                "email": ""
            },
            {
                "first": "Igor",
                "middle": [],
                "last": "Tsaur",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Johannes Gutenberg University",
                    "location": {
                        "settlement": "Mainz",
                        "country": "Germany"
                    }
                },
                "email": ""
            },
            {
                "first": "Axel",
                "middle": [],
                "last": "Haferkamp",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Johannes Gutenberg University",
                    "location": {
                        "settlement": "Mainz",
                        "country": "Germany"
                    }
                },
                "email": ""
            },
            {
                "first": "Hendrik",
                "middle": [],
                "last": "Borgmann",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Johannes Gutenberg University",
                    "location": {
                        "settlement": "Mainz",
                        "country": "Germany"
                    }
                },
                "email": ""
            }
        ]
    },
    "abstract": [],
    "body_text": [
        {
            "text": "urology. We evaluated patients' eligibility for telemedicine 23 according to the physician and examined the patients' 24 perspective by evaluating their willingness for telemedicine. E U R O P E A N U R O L O G Y X X X ( 2 0 1 9 ) X X X -X X X a v a i l a b l e a t w w w . s c i e n c e d i r e c t . c o m j o u r n a l h o m e p a g e : w w w . e u r o p e a n u r o l o g y . c o m",
            "cite_spans": [
                {
                    "start": 61,
                    "end": 63,
                    "text": "23",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "Article history: Accepted April 21, 2020",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Article info"
        },
        {
            "text": "Associate Editor: James Catto",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Article info"
        },
        {
            "text": "Keywords: Telehealth E-health Coronavirus Severe acute respiratory syndrome coronavirus 2 2019 novel coronavirus Outpatients",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Article info"
        },
        {
            "text": "The current coronavirus disease 2019 (COVID- 19) pandemic has placed considerable strain on hospital resources. We explored whether telemedicine (defined as a videoconference) might help. We undertook prospective structured phone interviews of urological patients (n = 399). We evaluated their suitability for telemedicine (judged by a panel of four physicians) and their risks from COVID-19 (10 factors for a poor outcome), and collected willingness for telemedicine and demographic data. Risk factors for an adverse outcome from COVID-19 infection were common (94.5% had one or more) and most patients (63.2%) were judged suitable for telemedicine. When asked, 84.7% of patients wished for a telemedical rather than a face-to-face consultation. Those Supplementary Fig. S1 ).",
            "cite_spans": [
                {
                    "start": 45,
                    "end": 48,
                    "text": "19)",
                    "ref_id": null
                },
                {
                    "start": 747,
                    "end": 752,
                    "text": "Those",
                    "ref_id": null
                }
            ],
            "ref_spans": [
                {
                    "start": 753,
                    "end": 774,
                    "text": "Supplementary Fig. S1",
                    "ref_id": null
                }
            ],
            "section": "Abstract"
        },
        {
            "text": "Patients with renal cancer had the highest number of risk 76 factors (median 5 [4] [5] [6] , followed by patients with Table 1 ).",
            "cite_spans": [
                {
                    "start": 79,
                    "end": 82,
                    "text": "[4]",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 83,
                    "end": 86,
                    "text": "[5]",
                    "ref_id": "BIBREF8"
                },
                {
                    "start": 87,
                    "end": 90,
                    "text": "[6]",
                    "ref_id": "BIBREF9"
                }
            ],
            "ref_spans": [
                {
                    "start": 119,
                    "end": 126,
                    "text": "Table 1",
                    "ref_id": "TABREF2"
                }
            ],
            "section": "75"
        },
        {
            "text": "The RKI recently stated the risk factors for a severe 87 outcome of COVID-19 [6] . These high-risk patients should are conducted in in-patient populations [8, 9] . acute respiratory disease, and pneumonia due to severe acute E U R O P E A N U R O L O G Y X X X ( 2 0 1 9 ) X X X -X X X",
            "cite_spans": [
                {
                    "start": 77,
                    "end": 80,
                    "text": "[6]",
                    "ref_id": "BIBREF9"
                },
                {
                    "start": 155,
                    "end": 158,
                    "text": "[8,",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 159,
                    "end": 161,
                    "text": "9]",
                    "ref_id": "BIBREF14"
                }
            ],
            "ref_spans": [],
            "section": "86"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Stepping forward: urologists' 168 efforts during the COVID-19 outbreak in Singapore",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "C"
                    ],
                    "last": "Chan",
                    "suffix": ""
                },
                {
                    "first": "Sek",
                    "middle": [],
                    "last": "Yeo",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "L"
                    ],
                    "last": "Chong",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "M"
                    ],
                    "last": "Lee",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "Eur Urol",
            "volume": "169",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1016/j.eururo.2020.03.004"
                ]
            }
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "triage of urologic surgeries during the COVID-19 pandemic",
            "authors": [],
            "year": null,
            "venue": "Eur",
            "volume": "171",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "press",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Urol",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1016/j.eururo.2020.03.027"
                ]
            }
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "Advice for Medical Oncology care of Urologi-172",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "P"
                    ],
                    "last": "Gillessen",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Powles",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "Urology practice during COVID-174",
            "authors": [
                {
                    "first": "V",
                    "middle": [],
                    "last": "Ficarra",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Novara",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Abrate",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "The current state of telemedi-176 cine in urology",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Miller",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Rhee",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Gettman",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Spitz",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Med Clin North Am",
            "volume": "102",
            "issn": "",
            "pages": "387--98",
            "other_ids": {}
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "SARS-CoV-2 Steck Q10 brief zur Coronavirus-177",
            "authors": [
                {
                    "first": "Robert",
                    "middle": [],
                    "last": "Koch Institute",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF10": {
            "ref_id": "b10",
            "title": "The effect of telehealth interven-180",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "L"
                    ],
                    "last": "Larson",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "B"
                    ],
                    "last": "Rosen",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [
                        "A"
                    ],
                    "last": "Wilson",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF12": {
            "ref_id": "b12",
            "title": "Asymptomatic carrier state, respiratory syndrome coronavirus 2 (SARS-CoV-2): facts and myths",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "C"
                    ],
                    "last": "Lai",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "H"
                    ],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "Y"
                    ],
                    "last": "Wang",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF13": {
            "ref_id": "b13",
            "title": "press",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1016/j.jmii.2020.02.012"
                ]
            }
        },
        "BIBREF14": {
            "ref_id": "b14",
            "title": "Clinical, laboratory and imaging features of COVID-19: a 187 systematic review and meta-analysis",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "J"
                    ],
                    "last": "Rodriguez-Morales",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "A"
                    ],
                    "last": "Cardona-Ospina",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Gutierrez-Ocampo",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "Travel Med Infect Dis. In",
            "volume": "188",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1016/j.tmaid.2020.101623"
                ]
            }
        },
        "BIBREF16": {
            "ref_id": "b16",
            "title": "press",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Respir",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1183/13993003.00547-2020"
                ]
            }
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "show that a large proportion (54.1%) of our 96 patients are eligible and willing to keep a telemedical 97 appointment if they were scheduled during the COVID-19 98 pandemic. In addition, we found a positive association 99 between a higher risk profile (odds ratio 1.71) and eligibility 100 for telemedicine. On the contrary, no association was found 101 between the number of risk factors and patients' wish for a 102 telemedical consultation (p = 0.1). It might be possible that 103 these patients do not reflect their own risk status or these 104 older patients are not able to provide the technical 105 requirements. 106 To the best of our knowledge, no data about COVID-19 107 risk factor distribution and urological diagnoses exist. Our 108 findings show that patients with urological malignancies 109 have a higher number of risk factors for a severe COVID-19 110 course than patients with nononcological disease (2 vs 4, 111 p < 0.001; data not shown). Oncological patients are older 112 than nononcological patients (71 vs 65 yr, p < 0.001; data 113 not shown), and immunosuppression is more commonly 114 used in cancer patients (3.2% vs 10.3%, p = 0.02; data not 115 shown). Larson et al [7] showed that telemedical interven-116 tion in cancer patients is comparable with face-to-face 117 interaction regarding quality of life. No data exist about 118 oncological outcome in patients who received telemedical 119 advice. 120 Our study is not without limitations. First, risk factors for 121 a severe outcome of COVID-19 are not validated. Most risk 122 factor analyses for an unfavourable outcome of COVID-19 123",
            "latex": null,
            "type": "figure"
        },
        "TABREF0": {
            "text": "favouring telemedicine were younger (68 [58-75] vs 76 [70-79.2] yr, p < 0.001). There was no difference in preference with oncological (mean 86%) or benign diagnoses (mean 85%), or with COVID-19 risks factors. In subgroup analysis, men with prostate cancer preferred telemedicine (odds ratio: 2.93 [1.07-8.03], p = 0.037). We concluded that many urological patients have risk factors for a poor outcome from COVID-19 and most preferred telemedicine consultations at this time. This appears to be a solution to offer contactfree continuity of care. Patient summary: Risk factors for a severe course of coronavirus disease 2019 are common (94.5%) in urology patients. Most patients wished for a telemedical consultation (84.7%). This appears to be a solution to offer contact-free continuity of care.\u00a9 2020 Published by Elsevier B.V. on behalf of European Association of Urology.Fig. 1 -Patients numbers stratified according to diagnosis, number of risk factors, and eligibility for telemedicine. The number of risk factors was calculated as a sum of age 50 yr, circulatory disease, diabetes, respiratory disease, liver disease, renal disease, history of oncological disease, immunosuppression at the time of the interview, nicotine abuse (actual abuse), and hypertension. Patients were classified as telemedicine eligible if the primary reason for their consultation can be solved completely by telemedicine. By contrast, if in-person/on-site services such as physical examination, current laboratory values, ultrasound, or other procedures were needed, patients were classified as telemedicine ineligible. COVID-19 = coronavirus disease 2019.",
            "latex": null,
            "type": "table"
        },
        "TABREF1": {
            "text": "Please cite this article in press as: Boehm K, et al. Telemedicine Online Visits in Urology During the COVID-19 Pandemic-Potential, Risk Factors, and Patients' Perspective. Eur Urol (2020), https://doi.org/10.1016/j.eururo.2020.04.055 Furthermore, we assessed the risk profile of urological patients for a poor outcome of COVID-19. We analysed 399 consecutive outpatients with scheduled appointments at our tertiary centre between October 2019 and February 2020. The institutional review board approved the study. All participants gave oral informed consent. Prospective structured phone interviews were conducted between 18 and 24 March 2020. Information about age, reason for consultation, and medical history were collected. Information about 10 risk factors for a poor outcome of COVID-19 according to the Robert-Koch Institute (RKI) for disease surveillance and prevention was gathered. The patients' perspective was evaluated by asking the following question: \"If your appointment was tomorrow during COVID-19 pandemic, would you prefer inhouse appointments or telemedicine contact?\" Telemedicine was defined as videoconference. Eligibility for telemedicine was evaluated by four experienced 44 physicians according to the patients' files at the time of 45 consultation. Patients were classified as telemedicine 46 eligible if their primary reason for consultation could be 47 solved completely by telemedicine. On the contrary, if 48 physical examination, current laboratory values, ultrasound, or other procedures were needed, patients were 50 considered telemedicine ineligible. Statistics were per-formed using RStudio v0.98.953 (R Project for Statistical Computing, www.R-project.org). The CONSORT diagram depicts the study design (Supplementary Fig. S1). The reason for consultation was mostly an oncological disease (243/399 patients, 60.9%). Most patients were older than 50 yr (346, 86.7%). Self-reported comorbidities consisted of cardiovascular disease (42.4%), diabetes (13.8%), pulmonary disease (16%), liver dysfunction 59 (12%), renal dysfunction (34.1%), oncological disease 60 (60.9%), and hypertension (56.1%). Immunosuppression was reported by 7.5% and a positive current smoking status consultation in case of pandemic. The reason for refusal of Eligibility for telemedicine was more prevalent in oncological patients than in nononcological patients (181 [74.4%] vs 71 [45.5%]; p < 0.001;",
            "latex": null,
            "type": "table"
        },
        "TABREF2": {
            "text": "Characteristics of patie Q2nts eligible for telemedicine (n = 252) stratified according to their wish for telemedical consultation (positive vs negative).",
            "latex": null,
            "type": "table"
        },
        "TABREF3": {
            "text": "ventilation[10]. Our risk factors are in line with these results.Taken together, our study adds some important information about patients' perspective on telemedical consultation during COVID-19 pandemic. We found that overall133 54.1% of our patients were both eligible and willing to be 134 scheduled for telemedical appointments. In addition, we 135 evaluated the number of risk factors for an unfavourable outcome of COVID-19 and urological condition, and found that patients with more risk factors and urological malignancies are significantly more often eligible for telemedicine. Author contributions: Katharina Boehm had full access to all the data in 141 the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: Boehm, Borgmann, Haferkamp. Acquisition of data: Ziewers, Brandt, Sparwasser, Haack, Willems, Thomas, Dotzauer, H\u00f6fner, Tsaur. Analysis and interpretation of data: Boehm, Borgmann. Drafting of the manuscript: Boehm, Borgmann, Brandt. Critical revision of the manuscript for important intellectual content: Ziewers, Brandt, Sparwasser, Haack, Willems, Thomas, Dotzauer, H\u00f6fner, Tsaur, Haferkamp. Statistical analysis: Boehm. Obtaining funding: None. Administrative, technical, or material support: None. Supervision: Boehm, Borgmann, Haferkamp. Other: Telephone interviews were conducted by Willems.Financial disclosures: Katharina Boehm certifies that all conflicts of interest, including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the 159 manuscript (eg, employment/affiliation, grants or funding, consultancies, honoraria, stock ownership or options, expert testimony, royalties, or patents filed, received, or pending), are the following: None. Funding/Support and role of the sponsor: None. Q8 Appendix A. Supplementary data Supplementary material related to this article can be found, in the online version, at doi:https://doi.org/10.1016/j. eururo.2020.04.055.",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": []
}